EGC is pleased to present a three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued commitment to providing valuable insights about the non-dilutive funding landscape to the scientific and entrepreneurial communities.
Session 1: Harvesting America’s Seed Fund: Guidance for navigating the NSF’s SBIR / STTR application process
Speaker: Dr. Dana Upton, MBA
Touted as America’s Seed Fund, the National Science Foundation’s (NSF) SBIR / STTR program provides early-stage funding to small businesses engaged in high-risk, high-reward R&D to help them develop and commercialize innovative technologies. Each year, the NSF provides more than $200 million in SBIR / STTR program awards to ~400 startups across nearly all technology areas including artificial intelligence, energy, medical devices, robotics, semiconductors, and many more.
Session 2: Leveraging Non-dilutive Funding for Drug Discovery and Development
Speakers: Dr. Connie Vance and Dr. Tiger Xie
This webinar covers key strategies for utilizing non-dilutive funding sources to support various stages of the drug discovery and development process. It also provides an overview of major government and private foundation funding opportunities that support the biopharma industry. Additionally, Dr. Vance and Dr. Xie share valuable tips on how to prepare competitive grant applications specifically tailored for drug discovery and development initiatives.
Session 3: Department of Energy funding for emerging businesses
Speakers: Dr. Lu Lu
During this session, Dr. Lu covered the fundamentals of the DOE SBIR / STTR program, including eligibility, application process, useful resources, success rate, and tips in preparing a competitive proposal. She also provided insights on ARPA-E and other non-dilutive funding opportunities available through the DOE.